Engineered Aldolase Polypeptides for Stereoselective Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current synthesis routes for β-hydroxy-α-amino acids suffer from poor stereoselectivity, leading to inefficient and environmentally burdensome processes due to the need for costly resolution and purification steps, which are not suitable for industrial applications.
Innovation Solution
Engineered aldolase polypeptides with enhanced stereoselectivity, stability, and catalytic activity are developed through directed evolution, allowing for the asymmetric synthesis of β-hydroxy-α-amino acids with high diastereomeric excess, specifically (2S, 3R)-2-amino-3-hydroxy-3-[4-(methylsulfonyl)phenyl] propanoic acid, using optimized gene sequences, recombinant expression vectors, and suitable reaction conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If chemical synthesis routes are used to produce β-hydroxy-α-amino acids, then production capacity is achieved, but stereoselectivity deteriorates leading to poor product quality
Solution Approach 1:
The patent replaces chemical synthesis mechanisms with enzymatic catalysis mechanisms. Engineered aldolase enzymes catalyze the condensation of aldehydes and amino acids to produce β-hydroxy-α-amino acids with high stereoselectivity, eliminating the need for complex chiral catalysts and resolution steps required in chemical synthesis.
Solution Approach 2:
The patent employs directed evolution to optimize enzyme parameters including amino acid sequence, catalytic activity, and stereoselectivity. Through multiple rounds of mutagenesis and selection, the enzyme parameters are tuned to achieve both high productivity and excellent stereoselectivity for the desired (2S,3R) diastereomer.
2Manufacturing precision
If resolution and purification steps are implemented to improve stereoselectivity, then product quality improves, but process complexity and cost increase
Solution Approach 1:
The patent extracts and eliminates the need for resolution and purification steps by using highly stereoselective engineered aldolase enzymes. The enzymatic reaction directly produces the desired (2S,3R) diastereomer with high enantiomeric excess, removing the requirement for subsequent separation processes.
Solution Approach 2:
The engineered aldolase enzyme performs self-selection of stereoisomers through its catalytic mechanism. The enzyme's active site architecture inherently favors the formation of the (2S,3R) diastereomer, providing built-in stereoselectivity without requiring external resolution steps.
3Ease of operation
If wild-type aldolase is used for synthesis, then process simplicity is maintained, but stereoselectivity deteriorates below industrial requirements
Solution Approach 1:
The patent performs preliminary optimization of the aldolase enzyme through directed evolution before industrial application. Multiple rounds of site-directed mutagenesis and screening are conducted to pre-optimize the enzyme's stereoselectivity and catalytic activity, ensuring that the final enzyme preparation meets industrial requirements without requiring complex process modifications.
Solution Approach 2:
The patent creates improved copies of the wild-type aldolase enzyme through genetic engineering. Specific amino acid residues are mutated to generate variant enzymes with enhanced stereoselectivity while maintaining the overall fold and catalytic mechanism of the original enzyme, thereby preserving process simplicity.
4Productivity
If chemical reagents are used in large quantities for synthesis, then reaction efficiency is achieved, but environmental burden increases due to waste generation
Solution Approach 1:
The patent substitutes chemical reagents with biocatalytic enzymes. The engineered aldolase catalyzes the reaction under mild aqueous conditions without requiring toxic reagents, heavy metals, or harsh solvents, thereby eliminating the environmental burden associated with chemical synthesis while maintaining high reaction efficiency.
Solution Approach 2:
The patent converts the traditionally harmful chemical synthesis process into an environmentally benign biocatalytic process. By using engineered enzymes, the reaction proceeds with high atom economy and generates minimal waste, transforming the harmful aspect of chemical synthesis into a sustainable green chemistry approach.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered aldolase polypeptides achieve high stereoselectivity and catalytic efficiency in the synthesis of β-hydroxy-α-amino acids, significantly improving yield and reducing environmental impact by minimizing the need for costly resolution and purification steps, thereby meeting industrial application requirements.
Implementation Method 1
aldolase can condense aldehydes and amino acids to form β-hydroxy-α-amino acids. The condition of this enzymatic reaction is mild and results in little pollution.
Data Source
AI summary
Provided herein are engineered polypeptides that are useful for the asymmetric synthesis of β-hydroxy-α-amino acids under industrial-relevant conditions. Also provided are polynucleotides encoding engineered polypeptides, host cells capable of expressing engineered polypeptides, and methods of producing β-hydroxy-α-amino acids using engineered polypeptides. Compared to other processes of preparation, the use of the engineered polypeptides for the preparation of β-hydroxy-α-amino acids results in high purity of the desired stereoisomers, mild reaction conditions, low pollution and low energy consumption.